Search

Search Constraints

You searched for: Author/Creator Cheng, Yin

Search Results

29. Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study. (September 2017)